AVRW — Avenir Wellness Solutions Share News
0.000.00%
Last trade - 00:00TechnologyHighly SpeculativeMicro Cap
- $0.02m
- $8.87m
- $4.35m
Brief: Cure Pharmaceutical Announces Rob Davidson As New Chairman Of The Board And Appointment Of Rob Costantino As Member Of The Board And Audit Committee Chairman
Brief: Cure Pharmaceutical Holding Q1 Revenue $1.5 Million
Brief: CURE Pharmaceutical Augments Its Existing U.S. DEA License
Brief: Cure Pharmaceutical Receives FDA Approval For Its IND Application For Curefilm Blue
Brief: Nicole Kidman Partners With Sera Labs As A Strategic Business Partner And Global Brand Ambassador
Embargo: Nicole Kidman to endorse U.S. cannabis company
Brief: Cure Pharmaceutical Closes $10 Million Financing
Brief: Cure Pharmaceutical- Filed A Demand To Commence Arbitration With American Arbitration Association Against Canopy Growth Corp
Brief: Cure Pharmaceutical To Acquire Sera Labs
Brief: Cure Pharmaceutical Names Canopy Rivers’ Chairman, John K. Bell To Board
Brief: Cure Pharmaceutical Secures Hemp CBD Supply Chain By Partnering With Fytiko Farms
Brief: Cure Pharmaceutical And Canopy Growth To Produce CBD Oral Thin Films
Brief: Cure Pharmaceutical Expands U.S. DEA Approval To Manufacture Pharmaceuticals Using Whole Cannabis Plant
Brief: Cure Pharmaceutical Announces Closing Of $1 Mln Bridge Financing And Prepares To Uplist To Nasdaq
Brief: Cure Pharma says Oak Therapeutics completes milestone in phase 1 of NIH grant